Recursion Pharmaceuticals, Inc. () News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 1282117,
    "name": "Recursion Pharmaceuticals, Inc.",
    "stock_name": "Recursion Pharmaceuticals, Inc.",
    "full_name": "Recursion Pharmaceuticals, Inc.",
    "name_url": "stocks-analysis/recursion-pharmaceuticals-inc",
    "exchange": 210,
    "exchangecode": "NAS",
    "country_id": 2,
    "currency": "USD",
    "cmp": "4.92",
    "chg": 0.6,
    "chgp": "13.89%",
    "dir": 1,
    "prev_price": "4.32",
    "mcapval": "2,008.14",
    "mcap": "Small Cap",
    "scripcode": "",
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 2320,
    "indexname": "S&P 500",
    "isin": "US75629V1044",
    "curr_date": "Dec 04",
    "curr_time": "",
    "bse_nse_vol": "39.81 M",
    "exc_status": "Active",
    "traded_date": "Dec 04, 2025",
    "traded_date_str": "2025 12 04",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/recursion-pharmaceuticals-inc-1282117-210&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Recursion Pharmaceuticals Hits Day Low at $4.60 Amid Price Pressure",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/recursion-pharmaceuticals-hits-day-low-at-460-amid-price-pressure-3680240",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/RecursionPharma_priceRelatedfactors_3680240.png",
        "date": "2025-11-07 16:36:09",
        "description": "Recursion Pharmaceuticals, Inc. has faced notable stock declines, with a year-to-date drop of 31.66% and a one-year decrease of 32.26%. The company reported negative financial results for two consecutive quarters, including a substantial net loss and low operating cash flow, indicating ongoing challenges in the pharmaceuticals sector."
      },
      {
        "title": "Recursion Pharmaceuticals Hits Day Low at $4.86 Amid Price Pressure",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/recursion-pharmaceuticals-hits-day-low-at-486-amid-price-pressure-3676133",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/RecursionPharma_priceRelatedfactors_3676133.png",
        "date": "2025-11-06 16:13:32",
        "description": "Recursion Pharmaceuticals, Inc. has faced a notable decline in its stock performance, with significant losses over various timeframes. The company reports a challenging financial situation, including a substantial net loss and negative return on equity, raising concerns about its market position within the pharmaceuticals and biotechnology sector."
      },
      {
        "title": "Recursion Pharmaceuticals, Inc. Experiences Evaluation Revision Amidst Market Dynamics and Performance Indicators",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/recursion-pharmaceuticals-technical-trend-shifts-from-mildly-bearish-to-sideways-amid-stock-price-increase-3652147",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/RecursionPharma_technicaldot_3652147.png",
        "date": "2025-10-28 16:01:32",
        "description": "Recursion Pharmaceuticals, Inc. has recently revised its evaluation amid changing market conditions. The stock has experienced fluctuations in price, with notable performance against the S&P 500 over the past week and month, although longer-term returns have faced challenges. Technical indicators present mixed signals regarding market sentiment."
      },
      {
        "title": "Is Recursion Pharmaceuticals, Inc. technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-recursion-pharmaceuticals-inc-technically-bullish-or-bearish-3651376",
        "imagepath": "",
        "date": "2025-10-28 11:41:47",
        "description": "As of 24 October 2025, the technical trend for Recursion Pharmaceuticals, Inc. has changed from mildly bearish to sideways. The current technical stance is neutral, with mixed indicators influencing this outlook. The weekly MACD is mildly bullish, while the monthly MACD also indicates a mildly bullish trend. However, the daily moving averages are mildly bearish, and the KST shows bearish signals on both weekly and monthly time frames. The Dow Theory supports a mildly bullish stance on both weekly and monthly periods, and the OBV is bullish in both time frames. \n\nIn terms of performance, the stock has outperformed the S&P 500 over the past week and month, returning 3.07% and 23.77% respectively, while it has underperformed over longer periods, including a -10.65% YTD return compared to the S&P 500's 15.47%. Overall, the mixed signals suggest a cautious approach...."
      },
      {
        "title": "Is Recursion Pharmaceuticals, Inc. technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-recursion-pharmaceuticals-inc-technically-bullish-or-bearish-3647831",
        "imagepath": "",
        "date": "2025-10-27 11:52:58",
        "description": "As of 24 October 2025, the technical trend for Recursion Pharmaceuticals, Inc. has changed from mildly bearish to sideways. The current stance is neutral, with mixed signals across different indicators. The MACD is mildly bullish on both weekly and monthly time frames, while the RSI shows no signal in both periods. The Bollinger Bands indicate a bullish weekly outlook but a mildly bearish monthly perspective. Moving averages are mildly bearish on a daily basis, and the KST is bearish in both weekly and monthly views. However, Dow Theory is mildly bullish on both time frames, and OBV is bullish in both weekly and monthly assessments.\n\nIn terms of performance, the stock has outperformed the S&P 500 over the past week and month, returning 3.07% and 23.77% respectively, while it has underperformed over longer periods, including a -10.65% YTD return compared to the S&P 500's 15.47%...."
      },
      {
        "title": "Is Recursion Pharmaceuticals, Inc. technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-recursion-pharmaceuticals-inc-technically-bullish-or-bearish-3646364",
        "imagepath": "",
        "date": "2025-10-26 11:27:28",
        "description": "As of 24 October 2025, the technical trend for Recursion Pharmaceuticals, Inc. has changed from mildly bearish to sideways. The current technical stance is neutral, with mixed signals across various indicators. The weekly MACD is mildly bullish, while the monthly MACD is also mildly bullish. However, the daily moving averages indicate a mildly bearish trend. The Bollinger Bands show a bullish signal on the weekly timeframe but are mildly bearish on the monthly. The KST is bearish on both weekly and monthly timeframes, while the Dow Theory indicates a mildly bullish stance on both timeframes. The On-Balance Volume (OBV) is bullish on both weekly and monthly timeframes.\n\nIn terms of performance, the stock has outperformed the S&P 500 over the past week and month, returning 3.07% and 23.77% respectively, while it has underperformed over the longer terms, with a year-to-date return of -10.65% compared to the S&..."
      },
      {
        "title": "Recursion Pharmaceuticals Hits Day High with 15.28% Surge in Stock Price",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/recursion-pharmaceuticals-hits-day-high-with-1528-surge-in-stock-price-3626715",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/RecursionPharma_priceRelatedfactors_3626715.png",
        "date": "2025-10-16 18:57:48",
        "description": "Recursion Pharmaceuticals, Inc. has seen a notable stock increase today, contrasting with a slight decline in the S&P 500. Despite recent gains, the company has struggled financially, reporting significant losses over the past year and negative results in its last two quarters, highlighting ongoing challenges in its operations."
      },
      {
        "title": "Recursion Pharmaceuticals Hits Day High with 16.44% Surge in Stock Price",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/recursion-pharmaceuticals-hits-day-high-with-1644-surge-in-stock-price-3608126",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/RecursionPharma_priceRelatedfactors_3608126.png",
        "date": "2025-10-09 20:56:03",
        "description": "Recursion Pharmaceuticals, Inc. saw a notable stock price increase on October 8, 2025, amid a declining S&P 500. Despite recent gains, the company has struggled with long-term performance and reported significant financial losses in the first half of the year, raising concerns about its market position."
      },
      {
        "title": "Recursion Pharmaceuticals Experiences Evaluation Revision Amidst Market Dynamics and Performance Indicators",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/recursion-pharmaceuticals-technical-trend-shifts-from-bearish-to-mildly-bearish-amid-stock-price-fluctuations-3601391",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/RecursionPharma_technicaldot_3601391.png",
        "date": "2025-10-07 21:04:11",
        "description": "Recursion Pharmaceuticals, Inc. has recently revised its evaluation amid market fluctuations, with its stock priced at $5.53. The company has experienced significant volatility over the past year, with a notable return of 12.63% over the past week, contrasting with a year-to-date decline of 18.20%."
      }
    ],
    "total": 19,
    "sid": "1282117",
    "stock_news_url": "https://www.marketsmojo.com/news/recursion-pharmaceuticals-inc-1282117"
  },
  "announcements": "",
  "corporate_actions": {
    "msg": "No corporate action Found"
  }
}

News and Views

Recursion Pharmaceuticals Hits Day Low at $4.60 Amid Price Pressure

2025-11-07 16:36:09

Recursion Pharmaceuticals, Inc. has faced notable stock declines, with a year-to-date drop of 31.66% and a one-year decrease of 32.26%. The company reported negative financial results for two consecutive quarters, including a substantial net loss and low operating cash flow, indicating ongoing challenges in the pharmaceuticals sector.

Recursion Pharmaceuticals Hits Day Low at $4.86 Amid Price Pressure

2025-11-06 16:13:32

Recursion Pharmaceuticals, Inc. has faced a notable decline in its stock performance, with significant losses over various timeframes. The company reports a challenging financial situation, including a substantial net loss and negative return on equity, raising concerns about its market position within the pharmaceuticals and biotechnology sector.

Recursion Pharmaceuticals, Inc. Experiences Evaluation Revision Amidst Market Dynamics and Performance Indicators

2025-10-28 16:01:32

Recursion Pharmaceuticals, Inc. has recently revised its evaluation amid changing market conditions. The stock has experienced fluctuations in price, with notable performance against the S&P 500 over the past week and month, although longer-term returns have faced challenges. Technical indicators present mixed signals regarding market sentiment.

Is Recursion Pharmaceuticals, Inc. technically bullish or bearish?

2025-10-28 11:41:47

As of 24 October 2025, the technical trend for Recursion Pharmaceuticals, Inc. has changed from mildly bearish to sideways. The current technical stance is neutral, with mixed indicators influencing this outlook. The weekly MACD is mildly bullish, while the monthly MACD also indicates a mildly bullish trend. However, the daily moving averages are mildly bearish, and the KST shows bearish signals on both weekly and monthly time frames. The Dow Theory supports a mildly bullish stance on both weekly and monthly periods, and the OBV is bullish in both time frames. In terms of performance, the stock has outperformed the S&P 500 over the past week and month, returning 3.07% and 23.77% respectively, while it has underperformed over longer periods, including a -10.65% YTD return compared to the S&P 500's 15.47%. Overall, the mixed signals suggest a cautious approach....

Is Recursion Pharmaceuticals, Inc. technically bullish or bearish?

2025-10-27 11:52:58

As of 24 October 2025, the technical trend for Recursion Pharmaceuticals, Inc. has changed from mildly bearish to sideways. The current stance is neutral, with mixed signals across different indicators. The MACD is mildly bullish on both weekly and monthly time frames, while the RSI shows no signal in both periods. The Bollinger Bands indicate a bullish weekly outlook but a mildly bearish monthly perspective. Moving averages are mildly bearish on a daily basis, and the KST is bearish in both weekly and monthly views. However, Dow Theory is mildly bullish on both time frames, and OBV is bullish in both weekly and monthly assessments. In terms of performance, the stock has outperformed the S&P 500 over the past week and month, returning 3.07% and 23.77% respectively, while it has underperformed over longer periods, including a -10.65% YTD return compared to the S&P 500's 15.47%....

Is Recursion Pharmaceuticals, Inc. technically bullish or bearish?

2025-10-26 11:27:28

As of 24 October 2025, the technical trend for Recursion Pharmaceuticals, Inc. has changed from mildly bearish to sideways. The current technical stance is neutral, with mixed signals across various indicators. The weekly MACD is mildly bullish, while the monthly MACD is also mildly bullish. However, the daily moving averages indicate a mildly bearish trend. The Bollinger Bands show a bullish signal on the weekly timeframe but are mildly bearish on the monthly. The KST is bearish on both weekly and monthly timeframes, while the Dow Theory indicates a mildly bullish stance on both timeframes. The On-Balance Volume (OBV) is bullish on both weekly and monthly timeframes. In terms of performance, the stock has outperformed the S&P 500 over the past week and month, returning 3.07% and 23.77% respectively, while it has underperformed over the longer terms, with a year-to-date return of -10.65% compared to the S&...

Recursion Pharmaceuticals Hits Day High with 15.28% Surge in Stock Price

2025-10-16 18:57:48

Recursion Pharmaceuticals, Inc. has seen a notable stock increase today, contrasting with a slight decline in the S&P 500. Despite recent gains, the company has struggled financially, reporting significant losses over the past year and negative results in its last two quarters, highlighting ongoing challenges in its operations.

Recursion Pharmaceuticals Hits Day High with 16.44% Surge in Stock Price

2025-10-09 20:56:03

Recursion Pharmaceuticals, Inc. saw a notable stock price increase on October 8, 2025, amid a declining S&P 500. Despite recent gains, the company has struggled with long-term performance and reported significant financial losses in the first half of the year, raising concerns about its market position.

Recursion Pharmaceuticals Experiences Evaluation Revision Amidst Market Dynamics and Performance Indicators

2025-10-07 21:04:11

Recursion Pharmaceuticals, Inc. has recently revised its evaluation amid market fluctuations, with its stock priced at $5.53. The company has experienced significant volatility over the past year, with a notable return of 12.63% over the past week, contrasting with a year-to-date decline of 18.20%.

View All News